National Financial Statements From 2010 to 2025

NHI Stock  USD 76.06  0.57  0.76%   
National Health financial statements provide useful quarterly and yearly information to potential National Health Investors investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on National Health financial statements helps investors assess National Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting National Health's valuation are summarized below:
Gross Profit
324.4 M
Profit Margin
0.4112
Market Capitalization
3.5 B
Enterprise Value Revenue
13.6366
Revenue
335.6 M
We have found one hundred twenty available fundamental ratios for National Health, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of National Health last-minute fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The National Health's current Market Cap is estimated to increase to about 3.2 B. The National Health's current Enterprise Value is estimated to increase to about 4.4 B

National Health Total Revenue

174.13 Million

Check National Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.8 M, Interest Expense of 58.9 M or Total Revenue of 174.1 M, as well as many indicators such as Price To Sales Ratio of 7.33, Dividend Yield of 0.0859 or PTB Ratio of 2.11. National financial statements analysis is a perfect complement when working with National Health Valuation or Volatility modules.
  
Check out the analysis of National Health Correlation against competitors.

National Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B2.6 B2.1 B
Slightly volatile
Short and Long Term Debt Total637.9 M1.1 B988.5 M
Slightly volatile
Total Stockholder Equity752.4 M1.4 B1.1 B
Slightly volatile
Property Plant And Equipment Net2.5 B2.4 B2.2 B
Slightly volatile
Net Debt1.2 B1.1 B949.8 M
Slightly volatile
Other Assets2.3 B2.2 B691.8 M
Slightly volatile
Common Stock Shares Outstanding32.5 M44.1 M36.5 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B2.6 B2.1 B
Slightly volatile
Non Current Liabilities Total1.3 B1.2 B972.1 M
Slightly volatile
Total Liabilities631.9 M1.2 B985.2 M
Slightly volatile
Property Plant And Equipment Gross250.9 M454 M371 M
Pretty Stable
Non Current Assets Total1.2 B2.2 B1.8 B
Slightly volatile
Net Receivables244.3 M370.4 M236.9 M
Slightly volatile
Total Current Assets262.7 M396.9 M262.2 M
Slightly volatile
Total Current Liabilities435.1 M414.4 M108 M
Slightly volatile
Accounts Payable39.6 M37.8 M20.1 M
Slightly volatile
Cash33.5 M24.3 M15.9 M
Slightly volatile
Cash And Short Term Investments46.9 M24.3 M17.4 M
Slightly volatile
Common Stock Total Equity351.3 K499.1 K387.3 K
Slightly volatile
Common Stock355.8 K499.1 K387.6 K
Slightly volatile
Short Term Debt347.8 M331.2 M117.7 M
Slightly volatile
Other Liabilities4.3 M4.5 M22.4 M
Slightly volatile
Long Term Debt673.3 M814.8 M904.2 M
Slightly volatile
Current Deferred Revenue4.6 M4.3 M5.5 M
Slightly volatile
Net Tangible Assets1.2 B1.5 B1.1 B
Slightly volatile
Capital Surpluse1.2 B1.8 B1.2 B
Slightly volatile
Long Term Investments187 M344.9 M205.9 M
Slightly volatile
Non Current Liabilities Other4.2 MM6.9 M
Slightly volatile
Property Plant Equipment1.9 B2.5 B1.8 B
Slightly volatile
Long Term Debt Total1.1 B1.3 B969 M
Slightly volatile
Short and Long Term Debt467.4 M331.2 M543.6 M
Slightly volatile
Cash And Equivalents18.5 M22.2 M12.9 M
Slightly volatile
Net Invested Capital2.1 B2.5 B2.5 B
Very volatile
Capital Stock488.6 K457 K438.3 K
Slightly volatile
Warrants7.9 M8.8 M9.6 M
Slightly volatile

National Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization37.8 M71.4 M63.1 M
Slightly volatile
Total Revenue174.1 M257 M219.5 M
Slightly volatile
Gross Profit172.3 M257 M216 M
Slightly volatile
Other Operating Expenses72.4 M42.3 M74.7 M
Slightly volatile
Operating Income225.5 M214.8 M146.8 M
Slightly volatile
EBIT202.3 M192.7 M134.2 M
Slightly volatile
EBITDA277.4 M264.2 M199.7 M
Slightly volatile
Net Income82.9 M137.9 M104.8 M
Pretty Stable
Selling General Administrative21.8 M20.7 M13.8 M
Slightly volatile
Cost Of Revenue10.6 M11.2 M10.8 M
Pretty Stable
Income Before Tax106.2 M137.9 M118.2 M
Slightly volatile
Net Income Applicable To Common Shares102.4 M76.4 M112.2 M
Very volatile
Extraordinary Items33.4 M31.8 M25 M
Slightly volatile
Discontinued Operations16.4 M31.8 M24 M
Slightly volatile
Net Income From Continuing Ops129.2 M136.6 M118.2 M
Slightly volatile
Reconciled Depreciation60.2 M71.4 M73.3 M
Pretty Stable
Selling And Marketing Expenses80 K90 K98.1 K
Slightly volatile

National Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation75 M71.4 M55.5 M
Slightly volatile
Total Cash From Operating Activities116.5 M207.8 M157.7 M
Slightly volatile
Net Income89.4 M136.6 M117.8 M
Slightly volatile
End Period Cash Flow30.5 M26.5 M17.6 M
Slightly volatile
Begin Period Cash Flow30.5 M24.6 M16.4 M
Slightly volatile
Dividends Paid97.8 M156.5 M128.8 M
Slightly volatile
Stock Based Compensation3.5 M4.2 M3.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.3311.820511.7131
Slightly volatile
Dividend Yield0.08590.05150.06
Pretty Stable
PTB Ratio2.112.223629.267
Slightly volatile
Days Sales Outstanding343526197
Slightly volatile
Book Value Per Share16.7531.592826.6794
Slightly volatile
Operating Cash Flow Per Share2.674.73873.9875
Slightly volatile
Stock Based Compensation To Revenue0.01310.01630.0155
Very volatile
Capex To Depreciation0.04570.04815.9178
Slightly volatile
PB Ratio2.112.223629.267
Slightly volatile
EV To Sales10.0616.184417.1324
Slightly volatile
ROIC0.110.08490.0714
Slightly volatile
Net Income Per Share1.983.14442.765
Pretty Stable
Payables Turnover0.20.30.2476
Pretty Stable
Sales General And Administrative To Revenue0.04330.08070.0606
Pretty Stable
Capex To Revenue0.010.01051.1348
Slightly volatile
Cash Per Share0.530.5540.636
Pretty Stable
POCF Ratio10.3414.624216.1737
Slightly volatile
Interest Coverage3.643.82756.2921
Slightly volatile
Payout Ratio1.191.13521.5718
Slightly volatile
Capex To Operating Cash Flow0.01740.01831.3989
Slightly volatile
Days Payables Outstanding1.2 K1.3 K3.3 K
Slightly volatile
Income Quality1.61.52061.4397
Slightly volatile
ROE0.09580.10090.43
Slightly volatile
EV To Operating Cash Flow20.0820.023324.6754
Slightly volatile
PE Ratio23.1422.038930.6817
Very volatile
Return On Tangible Assets0.07830.05270.0532
Slightly volatile
Earnings Yield0.07460.04540.0467
Very volatile
Net Debt To EBITDA3.994.24655.6147
Slightly volatile
Current Ratio0.910.95794.4166
Slightly volatile
Tangible Book Value Per Share25.5831.592850.666
Slightly volatile
Receivables Turnover0.660.6943.5161
Slightly volatile
Graham Number27.1446.957439.465
Pretty Stable
Shareholders Equity Per Share16.6831.166226.4808
Slightly volatile
Debt To Equity0.80.838736.0583
Slightly volatile
Capex Per Share0.07380.07765.3695
Slightly volatile
Revenue Per Share4.085.86275.5103
Slightly volatile
Interest Debt Per Share13.9427.418625.077
Slightly volatile
Debt To Assets0.440.43840.4578
Very volatile
Enterprise Value Over EBITDA11.8215.748918.4505
Slightly volatile
Short Term Coverage Ratios0.60.62730.6926
Pretty Stable
Price Earnings Ratio23.1422.038930.6817
Very volatile
Price Book Value Ratio2.112.223629.267
Slightly volatile
Days Of Payables Outstanding1.2 K1.3 K3.3 K
Slightly volatile
Dividend Payout Ratio1.191.13521.5718
Slightly volatile
Price To Operating Cash Flows Ratio10.3414.624216.1737
Slightly volatile
Pretax Profit Margin0.670.53630.5591
Slightly volatile
Ebt Per Ebit1.110.64180.9076
Slightly volatile
Operating Profit Margin0.70.83560.6861
Slightly volatile
Company Equity Multiplier1.821.913239.0383
Slightly volatile
Long Term Debt To Capitalization0.440.37360.4535
Pretty Stable
Total Debt To Capitalization0.450.45610.4745
Very volatile
Return On Capital Employed0.09460.09760.0735
Very volatile
Debt Equity Ratio0.80.838736.0583
Slightly volatile
Ebit Per Revenue0.70.83560.6861
Slightly volatile
Quick Ratio0.910.95799.5509
Pretty Stable
Dividend Paid And Capex Coverage Ratio1.441.32750.8507
Slightly volatile
Net Income Per E B T1.011.160.8845
Slightly volatile
Cash Ratio0.05570.05860.2149
Pretty Stable
Operating Cash Flow Sales Ratio0.550.80830.7244
Slightly volatile
Days Of Sales Outstanding343526197
Slightly volatile
Cash Flow Coverage Ratios0.170.18130.2102
Slightly volatile
Price To Book Ratio2.112.223629.267
Slightly volatile
Fixed Asset Turnover0.140.150.1301
Very volatile
Capital Expenditure Coverage Ratio42.1344.35219
Pretty Stable
Price Cash Flow Ratio10.3414.624216.1737
Slightly volatile
Enterprise Value Multiple11.8215.748918.4505
Slightly volatile
Debt Ratio0.440.43840.4578
Very volatile
Cash Flow To Debt Ratio0.170.18130.2102
Slightly volatile
Price Sales Ratio7.3311.820511.7131
Slightly volatile
Return On Assets0.08140.05270.0594
Slightly volatile
Asset Turnover0.150.09830.1072
Slightly volatile
Net Profit Margin0.440.53630.5274
Slightly volatile
Gross Profit Margin1.081.110.9979
Slightly volatile
Price Fair Value2.112.223629.267
Slightly volatile
Return On Equity0.09580.10090.43
Slightly volatile

National Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.2 BB2.4 B
Slightly volatile
Enterprise Value4.4 B4.2 B3.4 B
Slightly volatile

National Fundamental Market Drivers

Forward Price Earnings12.837
Cash And Short Term Investments24.3 M

National Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About National Health Financial Statements

Investors use fundamental indicators, such as National Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although National Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue4.3 M4.6 M
Total Revenue257 M174.1 M
Cost Of Revenue11.2 M10.6 M
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.08  0.04 
Capex To Revenue 0.01  0.01 
Revenue Per Share 5.86  4.08 
Ebit Per Revenue 0.84  0.70 

Currently Active Assets on Macroaxis

When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:
Check out the analysis of National Health Correlation against competitors.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.14)
Dividend Share
3.6
Earnings Share
3.13
Revenue Per Share
7.654
Quarterly Revenue Growth
(0.12)
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.